↑ 薬物リストへ　← 戻る

Group a sle prospective study    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
49全身性エリテマトーデス1

49. 全身性エリテマトーデス　［臨床試験数：827，薬物数：638（DrugBank：168），標的遺伝子数：108，標的パスウェイ数：191］
Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 827 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00987831
(ClinicalTrials.gov)		May 200930/9/2009Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)Biomarkers of Lupus Disease: Study of Biomarker Changes Before and After Treatment With Depomedrol and Background Medication Withdrawal in Patients With Mild to Moderate SLE Disease ActivitySystemic Lupus ErythematosusOther: Group B SLE one blood donation;Other: Blood drawing only Group C;Drug: Group A SLE prospective studyOklahoma Medical Research FoundationPfizerCompleted14 Years70 YearsAll158Phase 1;Phase 2United States